Identifying Microbiome Biomarkers Implicated in Lung Cancer
NYU Langone’s Dr. Harvey I. Pass and colleagues have begun identifying microbiome biomarkers implicated in lung cancer.
Identifying Why Immunotherapy Doesn’t Work in Some Cancers
Researchers at NYU Langone’s Perlmutter Cancer Center have identified why immunotherapies are ineffective in some cancers.
IEHE_Policy_Brief_Digital Health_FINAL_FULL
DI GI TAL HEALTH EQUI TY: Inst itute for Excellence in Health Equity Policy Brief Series May, 2025 Saf ...
If Caught Early, Hair Loss Can Be Slowed or Even Reversed
A researcher at NYU Langone’s Department of Dematology discusses the causes and potential treatments for hair loss.
igniting-a-transformation.pdf
Brian Elbel, PhD, MPH Director of the Comprehensive Program on Obesity Associate Professor, Department ...
IL-17 Activated HIF-1-alpha Drives Skin Inflammation.
An NYU Langone study shows that activation of protein HIF-1-alpha is at the crux of metabolic dysfunction observed in psoriasis.
Imaging Facility Guidelines NYU
Imaging Facility Guidelines for Acknowledgement 1 2 3 Im ag e A cq ui sit io n Fast, routine sample preparation ...
Imaging Overused for Breast & Prostate Cancers
New study concludes some patients with low-risk prostate or breast cancer may receive inappropriate imaging, based on where they received care.
Immune Cell Could Help Explain—& Temper—Food Allergies
NYU Langone has discovered an immune cell that could shed light on the basis of food allergies and some gastrointestinal-based autoimmune diseases.
Immune Cell Type ‘Quietly’ Controls Inflammation in COVID-19
NYU Langone study shows a type of immune cell in the lungs may help prevent inflammation from spiraling out of control during COVID-19.